MASHINIi

CeriBell, Inc..

CBLL.US | Manufacture of medical and dental instruments and supplies

CeriBell, Inc. (CBLL.US) is involved in the design, development, manufacture, and marketing of medical devices. The company focuses on creating innovative solutions for neurological conditions. Their primary products include devices used in neurosurgery, neuromodulation, and neurodiagnostics. CeriBe...Show More

Ethical Profile

Mixed.

Not enough information to create an ethical profile.

Value Scores

Better Health for All20
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

20

CeriBell's core products, such as the Rapid Response EEG system and Clarity™ Algorithm, deliver transformative health benefits by enabling rapid detection and diagnosis of non-convulsive seizures in both pediatric and adult patients. Clinical studies show 100% sensitivity for detecting seizures with Ceribell, compared to 78% with clinical judgment alone, leading to 4.1-day shorter median ICU stays and 18% more patients with better neurological outcomes.

1
The company's products have no established negative health outcomes, indicating no revenue from harmful products. A single adverse event report in March 2024 noted a device malfunction where it was unable to upload a recording, but no patient harm was reported, thus it is considered a neutral safety impact.
2
The company's clinical trials, including the DECIDE study, are described as prospective, multi-center trials, and the FDA cleared the Rapid-EEG system in 2018 and the Clarity™ algorithm in April 2025.
3

Fair Money & Economic Opportunity

0

No evidence available to assess CeriBell, Inc. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

No evidence available to assess CeriBell, Inc. on Fair Pay & Worker Respect.

Fair Trade & Ethical Sourcing

0

No evidence available to assess CeriBell, Inc. on Fair Trade & Ethical Sourcing.

Honest & Fair Business

0

No evidence available to assess CeriBell, Inc. on Honest & Fair Business.

Kind to Animals

0

No evidence available to assess CeriBell, Inc. on Kind to Animals.

No War, No Weapons

0

No evidence available to assess CeriBell, Inc. on No War, No Weapons.

Planet-Friendly Business

0

No specific, concrete data points related to environmental performance, climate action, or sustainable operations were found in the provided article. The article primarily focuses on financial results, including revenue, gross margin, operating expenses, and net loss for Q3 2024, as well as details about the company's IPO and product approvals.

1
Therefore, it is not possible to assess CeriBell, Inc. against the 'Planet-Friendly Business' value based on the available evidence.

Respect for Cultures & Communities

0

No quantitative data or specific information regarding CeriBell, Inc.'s performance on Respect for Cultures & Communities was provided in the available article.

1
The article explicitly states it is a placeholder and contains no relevant data for assessment.
2

Safe & Smart Tech

0

No evidence available to assess CeriBell, Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

No specific, quantitative evidence was found in the provided articles to assess CeriBell, Inc. against any of the 'Zero Waste & Sustainable Products' KPIs. The articles either discuss general industry principles, refer to a different company (Cerence, not CeriBell), or their content was not accessible.

1

Own CeriBell, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.